Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC
Recruiting · NCT03769129 · Registry updated 2024-06-25Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Recruiting | Not applicable | 2024-06-25 | NCT03769129 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Second Affiliated Hospital of Guangzhou Medical University | 70 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| zhang Zhenfeng | Guangzhou | China | 1 |